Treatment of a patient with conjunctival melanoma and V600E-positive BRAF mutation status with Vemurafenib

被引：0
|
作者：
Kiecker, Felix
Ewald, Kerstin
Bertelmann, Eckart
Trefzer, Uwe
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2012年 / 10卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [21] Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal
    Beale, Sophie
    Dickson, Rumona
    Bagust, Adrian
    Blundell, Michaela
    Dundar, Yenal
    Boland, Angela
    Marshall, Ernie
    Plummer, Ruth
    Proudlove, Chris
    PHARMACOECONOMICS, 2013, 31 (12) : 1121 - 1129
  • [22] Dabrafenib in advanced melanoma with BRAF V600E mutation
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 48 - 49
  • [23] BRAINSTEM LOW GRADE TUMORS PRESENTING WITH BRAF V600E MUTATION AND SUCCESSFUL TREATMENT WITH VEMURAFENIB
    Hemenway, Molly
    Madden, Jennifer
    Macy, Margaret
    Foreman, Nicholas
    Rush, Sarah
    NEURO-ONCOLOGY, 2012, 14 : 75 - 76
  • [24] NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma
    Perampaladas, Kumar
    Hay, Nicola
    Rinaldi, Fiona
    Robertson, Janet
    Adam, Jane
    LANCET ONCOLOGY, 2013, 14 (01): : 21 - 22
  • [25] Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
    Ceccon, Garry
    Werner, Jan-Michael
    Dunkl, Veronika
    Tscherpel, Caroline
    Stoffels, Gabriele
    Brunn, Anna
    Deckert, Martina
    Fink, Gereon R.
    Galldiks, Norbert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [26] Incidence and management of skin-related adverse events associated with vemurafenib in BRAF V600E-positive metastatic melanoma: a 3-year retrospective cohort study of 107 patients
    Sinha, R.
    Larkin, J.
    Gore, M. E.
    Fearfield, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 : 5 - 5
  • [27] Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
    Sahadudheen, K.
    Islam, Md. Rafiqul
    Iddawela, M.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2016, 2016
  • [28] Prognostic impact of BRAF-V600E expression and correlation with mutation status in cutaneous melanoma
    Hugdahl, Emilia
    Kalvenes, May Britt
    Puntervill, Hanne
    Ladstein, Rita
    Akslen, Lars A.
    CANCER RESEARCH, 2016, 76
  • [29] RECURRENT GANGLIOGLIOMA WITH BRAF V600E MUTATION RESPONSE TO VEMURAFENIB: CASE REPORT
    Aguilera, Dolly
    Mazewski, Claire
    Janss, Anna
    Castellino, Robert Craig
    Schniederjan, Matthew
    Hayes, Laura
    Brahma, Barun
    MacDonald, Tobey
    NEURO-ONCOLOGY, 2014, 16 : 61 - 61
  • [30] Rosai-Dorfman disease disguised as BRAF V600E-positive histiocytosis - a diagnostic pitfall
    Ravindran, Aishwarya
    Goyal, Gaurav
    Morlote, Diana
    Mackinnon, Alexander C.
    BLOOD RESEARCH, 2025, 60 (01)
12345